DiaMedica Therapeutics Inc. — Investor Relations & Filings
DiaMedica Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapies for serious ischemic and vascular diseases with significant unmet medical needs. The company's lead drug candidate is DM199, a recombinant form of the human tissue kallikrein-1 (rhKLK1) protein. DM199 is designed to restore vascular health and function through a novel mechanism of action, aiming to improve patient outcomes by reversing the effects of ischemic injury. The development programs are primarily focused on treating acute ischemic stroke (AIS), preeclampsia (PE), and fetal growth restriction (FGR), conditions for which there are currently limited or no approved therapies available to address the underlying disease.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| FORM 8-K | 2026-05-21 | English | |
| SCHEDULE 13G/A Filing | 2026-02-17 | English | |
| SCHEDULE 13G/A Filing | 2026-02-17 | English | |
| SCHEDULE 13G/A Filing | 2026-02-06 | English | |
| 4 Filing | 2026-01-06 | English | |
| 4 Filing | 2026-01-06 | English |
Browse filings by year
11 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
8 filings
| |||||
| 46753318 | FORM 8-K | 2026-05-21 | English | ||
| 29411421 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 29411396 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 29411398 | SCHEDULE 13G/A Filing | 2026-02-06 | English | ||
| 29411401 | 4 Filing | 2026-01-06 | English | ||
| 29411400 | 4 Filing | 2026-01-06 | English | ||
| 29411386 | 4 Filing | 2026-01-06 | English | ||
| 12157498 | FORM 8-K | 2026-01-05 | English | ||
|
2025
7 filings
| |||||
| 12157495 | FORM 8-K | 2025-12-18 | English | ||
| 12157499 | OWNERSHIP DOCUMENT | 2025-12-08 | English | ||
| 12157500 | Director's Dealing 2025 | 2025-11-25 | English | ||
| 12157504 | FORM S-8 | 2025-11-13 | English | ||
| 12157508 | FORM 10-Q | 2025-11-12 | English | ||
| 12157502 | FORM 8-K | 2025-11-12 | English | ||
| 12157509 | Major Shareholding Notification 2025 | 2025-11-07 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Abliva
Biopharmaceutical company developing medicines for primary …
|
ABLI | SE | Manufacturing |
|
AB Science
Researches and develops protein kinase inhibitors for human…
|
AB | FR | Manufacturing |
|
ABVC BIOPHARMA, INC.
Develops botanical drugs and medical devices for oncology, …
|
ABVC | US | Manufacturing |
|
ACADIA PHARMACEUTICALS INC
Biopharmaceutical company developing medicines for CNS diso…
|
ACAD | US | Manufacturing |
|
Access Bio, Inc.
Develops and manufactures in vitro diagnostic solutions for…
|
950130 | IN | Manufacturing |
|
Accretion Nutraveda Limited
Develops and manufactures pharmaceutical, nutraceutical, an…
|
544694 | IN | Manufacturing |
|
Accretion Pharmaceuticals Limited
Develops and manufactures therapeutic formulations across d…
|
ACCPL | IN | Manufacturing |
|
Acerus Pharmaceuticals Corporation
Specialty pharmaceutical company focused on developing and …
|
ASPCF | CA | Manufacturing |
|
ACHIEVE LIFE SCIENCES, INC.
A late-stage pharmaceutical company developing a treatment …
|
ACHV | US | Manufacturing |
|
Achyut Healthcare Limited
Procures, trades, and manufactures pharmaceutical APIs and …
|
543499 | IN | Manufacturing |
DiaMedica Therapeutics Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33140/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33140 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33140 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33140 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33140}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for DiaMedica Therapeutics Inc. (id: 33140)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.